Overlapping activities of TGF-β and Hedgehog signaling in cancer: therapeutic targets for cancer treatment.
about
A microRNA code for prostate cancer metastasis.Combining antibody-directed presentation of IL-15 and 4-1BBL in a trifunctional fusion protein for cancer immunotherapy.Crosstalk between Shh and TGF-β signaling in cyclosporine-enhanced cell proliferation in human gingival fibroblasts.Synergistic inhibition of colon carcinoma cell growth by Hedgehog-Gli1 inhibitor arsenic trioxide and phosphoinositide 3-kinase inhibitor LY294002.SOX18 Is a Novel Target Gene of Hedgehog Signaling in Cervical Carcinoma Cell Lines.GLI1 finds a new role in cancer stem cell biology.Common pathways regulate Type III TGFβ receptor-dependent cell invasion in epicardial and endocardial cells.Sclareolide enhances gemcitabine‑induced cell death through mediating the NICD and Gli1 pathways in gemcitabine‑resistant human pancreatic cancer.Insights into the Transforming Growth Factor-β Signaling Pathway in Cutaneous Melanoma.Signaling Cross Talk between TGF-β/Smad and Other Signaling Pathways.GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells.The oncogenic GLI transcription factors facilitate keratinocyte survival and transformation upon exposure to genotoxic agents.Ursolic acid suppresses TGF-β1-induced quiescent HSC activation and transformation by inhibiting NADPH oxidase expression and Hedgehog signaling.Thrombospondin-4 mediates TGF-β-induced angiogenesis.Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma.SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer.A prognostic regulatory pathway in stage I epithelial ovarian cancer: new hints for the poor prognosis assessment.A targeted transforming growth factor-beta (TGF-β) blocker, TTB, inhibits tumor growth and metastasis.Hedgehog signalling pathway inhibitors as cancer suppressing agents
P2860
Q27310006-A9B29276-CEDA-4090-BC37-BBEE1180F833Q30580198-0C37E276-2E50-487B-8339-2725986DF017Q34906074-06655EBF-EE15-436F-A5C9-43F0A910A70EQ35531884-8E45C77F-C1E4-4DD0-BB0F-8AD56A491E88Q35847295-2B97B4D1-8BEC-4F99-BE78-CBBE2ACE7374Q36771311-3EA5913F-BB81-4EE3-A567-D4E34AFA678BQ36786619-2C9131F3-609A-4A83-A410-1E8CDF9945B1Q37720259-D47421FB-2057-4647-97E7-C01BABB08E8FQ38110273-F3338D5A-607A-4F20-81EC-51FC660DE3CEQ39005862-4DE8D8A5-5ED7-4E25-B648-E2D8A44E5BFAQ39119914-E0A25102-C5D4-4D3D-9184-2BACB7A99634Q39136441-8ADAEA62-B082-4E51-950E-A2AE62D9319AQ42376330-9DCE5AF3-7709-4BC3-88E7-8F075B8DF27BQ43400597-58C5F053-EE02-40FC-BBCF-0A07C4FF12E8Q49251004-171C1A3E-CB31-48A5-B907-F820736ADF9BQ49885029-6AA414FA-9AC4-40AF-9E3F-DAE72D376375Q50858313-83041B9A-2CB9-4C86-8758-7BFF2EB106A9Q55129510-12FD9E63-BC42-48DC-BD1A-02B5B18BAA86Q57905193-84877E06-68ED-47D6-B46E-F467BC5E6463
P2860
Overlapping activities of TGF-β and Hedgehog signaling in cancer: therapeutic targets for cancer treatment.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Overlapping activities of TGF- ...... targets for cancer treatment.
@ast
Overlapping activities of TGF- ...... targets for cancer treatment.
@en
Overlapping activities of TGF- ...... targets for cancer treatment.
@nl
type
label
Overlapping activities of TGF- ...... targets for cancer treatment.
@ast
Overlapping activities of TGF- ...... targets for cancer treatment.
@en
Overlapping activities of TGF- ...... targets for cancer treatment.
@nl
prefLabel
Overlapping activities of TGF- ...... targets for cancer treatment.
@ast
Overlapping activities of TGF- ...... targets for cancer treatment.
@en
Overlapping activities of TGF- ...... targets for cancer treatment.
@nl
P1476
Overlapping activities of TGF- ...... c targets for cancer treatment
@en
P2093
Carole Y Perrot
P304
P356
10.1016/J.PHARMTHERA.2012.10.002
P577
2012-10-11T00:00:00Z